Thanks Flash and if you are having a hell of a time finding past AD studies with individual participants improving and stabilizing similar to our Anavex trial through 57 weeks (particularly on a blood concentration dependent basis), then I’m not sure how you think I’ll be able to beat your research skills.
And not to be glib, but if Dr George Perry had this to say (a year ago):
[George Perry, PhD, Dean and Professor at the University of Texas at San Antonio and Editor-in Chief of the Journal of Alzheimer’s Disease, commented, “Although this is an open label study with 32 patients, I have never seen mild-to-moderate Alzheimer’s patients maintain near baseline cognitive and activities of daily living function and positive correlation with all other measures over a 41-week trial period in any prior study with an approved or experimental drug. It is quite plausible that complex CNS diseases like Alzheimer’s may require a comprehensive approach, including restoration of cellular homeostasis.”]
Then shouldn’t a non-scientific mind, such as myself, be able to take more stock in his research/experience than any google search of my own?
I’d welcome any poster to provide examples of Anavex-level percentages of improvement/stabilization (either 7 of 25 or 5 of 9) over 57 weeks.
I’ve simply never before seen such examples. Ready to learn however.
GLTAL
AI
Market Data 
Markets 
